Development of lipopeptides for inhibiting 20S proteasomes.
Nicolas Basse, David Papapostolou, Maurice Pagano, Michèle Reboud-Ravaux, Elise Bernard, Anne-Sophie Felten, Régis Vanderesse
Index: Bioorg. Med. Chem. Lett. 16 , 3277-81, (2006)
Full Text: HTML
Abstract
Proteasomes are responsible for the cytoplasmic turnover of the vast majority of proteins including regulatory proteins. We have synthesized lipopeptides a new class of non-covalent inhibitors of the 20S proteasome and assayed their inhibitory capacities. Their ability to inhibit at micromolar concentrations chymotrypsin-like and post-acid activities depends on peptide length (3 or 6 amino acids), sequence (presence of a positively or negatively charged amino acid), and alkyl chain length (C6-C18). These structural features could be varied to selectively inhibit one or more of the three proteasome activities.
Related Compounds
Related Articles:
2015-01-01
[J. Food Sci. 80(1) , E101-7, (2015)]
Capillary atmospheric pressure chemical ionization using liquid point electrodes.
2014-07-30
[Rapid Commun. Mass Spectrom. 28(14) , 1591-600, (2014)]
2015-11-01
[Ultrason. Sonochem. 27 , 530-5, (2015)]
2015-09-01
[Bioresour. Technol. 191 , 306-11, (2015)]
2016-01-01
[Bioresour. Technol. 200 , 853-60, (2015)]